PEROXIDASE-CATALYSED COVALENT BINDING OF THE ANTITUMOR DRUG 2N-METHYL-9-HYDROXY-ELLIPTICINE TO PROTEINS

被引：22

作者：

AUCLAIR, C ^{[1
]}

MEUNIER, B ^{[1
]}

PAOLETTI, C ^{[1
]}

机构：

[1] LAB CHIM COORDINAT,F-31400 TOULOUSE,FRANCE

来源：

BIOCHEMICAL PHARMACOLOGY | 1983年 / 32卷 / 24期

关键词：

D O I：

10.1016/0006-2952(83)90170-3

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

收藏

页码：3883 / 3886

页数：4

相关论文

共 4 条

[1] BIOACTIVATION OF THE ANTI-TUMOR DRUGS 9-HYDROXYELLIPTICINE AND DERIVATIVES BY A PEROXIDASE HYDROGEN-PEROXIDE SYSTEM
AUCLAIR, C
PAOLETTI, C
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 1981, 24 (03) : 289 - 295
[2] PRELIMINARY TRIAL OF 9-HYDROXY-2-METHYL ELLIPTICINIUM (NSC 264-137) IN ADVANCED HUMAN CANCERS
JURET, P
TANGUY, A
GIRARD, A
LETALAER, JY
ABBATUCCI, JS
DATXUONG, N
LEPECQ, JB
PAOLETTI, C
[J]. EUROPEAN JOURNAL OF CANCER, 1978, 14 (02) : 205 - 206
[3] LEPECQ JB, 1975, CR ACAD SCI D NAT, V281, P1365
[4] UNEXPECTED REGIOSPECIFIC ALKYLATION OF THE ANTI-TUMOR AGENT N-2-METHYL-9-HYDROXYELLIPTICINIUM ACETATE WITH N-DONORS, O-DONORS OR S-DONORS
MEUNIER, G
MEUNIER, B
AUCLAIR, C
BERNADOU, J
PAOLETTI, C
[J]. TETRAHEDRON LETTERS, 1983, 24 (04) : 365 - 368